Skip to main content
SpringerLink
Log in

Lymphokine Racketeers?

  • Feature
  • Published:

From Nature Biotechnology

View current issue Submit your manuscript

Cistron alleges foul play over IL-1, but Immunex sees it differently

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Auron, P.E. et al. 1984. Natl. Acad. Sci. USA 81: 7907–7911.

    Article  CAS  Google Scholar 

  2. Marshall, E. 1995. Science 270: 1912–1914.

    Article  CAS  Google Scholar 

  3. Hassler, S. 1996. Bio/Technology 14: 14

    CAS  Google Scholar 

  4. Wolff, S.M. et al. 1986. Nature. 319: 270.

    Article  CAS  Google Scholar 

  5. March, C.J. et al. 1986. Nature. 315: 641–647.

    Article  Google Scholar 

  6. Kronheim, S. et al. 1985. J. Exp. Med. 101: 490–502.

    Article  Google Scholar 

  7. Cerrettl, D.P. et al. 1992. Science. 256: 97–100.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. a biotechnology industry consultant and freelance writer located in Seattle, Washington

    Thomas P. Hopp

Authors
  1. Thomas P. Hopp
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hopp, T. Lymphokine Racketeers?. Nat Biotechnol 14, 275–279 (1996). https://doi.org/10.1038/nbt0396-275

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nbt0396-275

  • Springer Nature America, Inc.

Search

Navigation